Viewing Study NCT01820260


Ignite Creation Date: 2025-12-25 @ 2:14 AM
Ignite Modification Date: 2026-01-08 @ 1:48 AM
Study NCT ID: NCT01820260
Status: COMPLETED
Last Update Posted: 2025-03-13
First Post: 2013-03-25
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Efficacy of Ingenol Mebutate Once Daily for 2 or 3 Consecutive Days in Subjects With Actinic Keratosis
Sponsor: LEO Pharma
Organization: